Answers are grounded in this paper and cite their sources.
A glucose-responsive closed-loop insulin delivery system mimicking pancreas activity without long-term side effect has the potential to improve diabetic patients’ health and quality of life. Here, we developed a novel glucose-responsive insulin delivery device using a painless microneedle-array patch containing insulin-loaded vesicles. Formed by self-assembly of hypoxia and H 2 O 2 dual-sensitive diblock copolymer, the glucose-responsive polymersome-based vesicles ( d -GRPs) can disassociate and subsequently release insulin triggered by H 2 O 2 and hypoxia generated during glucose oxidation catalyzed by glucose specific enzyme. Moreover, the d -GRPs were able to eliminate the excess H 2 O 2, which may lead to free radical-induced damage to skin tissue during the long-term usage and reduce the activity of GOx. In vivo experiments indicated that this smart insulin patch could efficiently regulate the blood glucose in the chemically induced type 1 diabetic mice for 10 h.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: